| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.4 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |